ReP USP - Resultado da busca

Artigo de periodico
The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol (2023)
Hartmann, Alice; Vila-Verde, Carla ; Guimarães, Francisco Silveira ; Wegener, Sâmia Regiane Lourenço Joca ; Lisboa, Sabrina Francesca de Souza
Source: Current Neuropharmacology. Unidades: FMRP, FCFRP, IRI
Subjects: CANABINOIDES, INFLAMAÇÃO, TECIDO NERVOSO, DEGENERAÇÃO NEURAL, DOENÇAS DO SISTEMA NERVOSO, TRANSTORNOS PSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HARTMANN, Alice et al. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol. Current Neuropharmacology, v. 21, n. 2, p. 284-308, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570159X20666220411101217. Acesso em: 23 ago. 2024.
APA
Hartmann, A., Vila-Verde, C., Guimarães, F. S., Wegener, S. R. L. J., & Lisboa, S. F. de S. (2023). The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol. Current Neuropharmacology, 21( 2), 284-308. doi:10.2174/1570159X20666220411101217
NLM
Hartmann A, Vila-Verde C, Guimarães FS, Wegener SRLJ, Lisboa SF de S. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol [Internet]. Current Neuropharmacology. 2023 ; 21( 2): 284-308.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/1570159X20666220411101217
Vancouver
Hartmann A, Vila-Verde C, Guimarães FS, Wegener SRLJ, Lisboa SF de S. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol [Internet]. Current Neuropharmacology. 2023 ; 21( 2): 284-308.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/1570159X20666220411101217
Artigo de periodico
The role of celecoxib as a potential inhibitor in the treatment of inflammatory diseases: a review (2022)
Cruz, Josiane Viana; Rosa, Joaquín Maria Campos; Kimani, Njogu Mark; Giuliatti, Silvana ; Santos, Cleydson Breno Rodrigues dos
Source: Current Medicinal Chemistry. Unidade: FMRP
Subjects: INFLAMAÇÃO, ANTI-INFLAMATÓRIOS, TOXICOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZ, Josiane Viana et al. The role of celecoxib as a potential inhibitor in the treatment of inflammatory diseases: a review. Current Medicinal Chemistry, v. 29, n. 17, p. 3028-3049, 2022Tradução . . Disponível em: https://doi.org/10.2174/0929867328666210910125229. Acesso em: 23 ago. 2024.
APA
Cruz, J. V., Rosa, J. M. C., Kimani, N. M., Giuliatti, S., & Santos, C. B. R. dos. (2022). The role of celecoxib as a potential inhibitor in the treatment of inflammatory diseases: a review. Current Medicinal Chemistry, 29( 17), 3028-3049. doi:10.2174/0929867328666210910125229
NLM
Cruz JV, Rosa JMC, Kimani NM, Giuliatti S, Santos CBR dos. The role of celecoxib as a potential inhibitor in the treatment of inflammatory diseases: a review [Internet]. Current Medicinal Chemistry. 2022 ; 29( 17): 3028-3049.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/0929867328666210910125229
Vancouver
Cruz JV, Rosa JMC, Kimani NM, Giuliatti S, Santos CBR dos. The role of celecoxib as a potential inhibitor in the treatment of inflammatory diseases: a review [Internet]. Current Medicinal Chemistry. 2022 ; 29( 17): 3028-3049.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/0929867328666210910125229
Artigo de periodico
Recent advances in molecular hydrogen research reducing exercise-induced oxidative stress and inflammation (2021)
Nogueira, Jonatas Evandro ; Branco, Luiz Guilherme de Siqueira
Source: Current Pharmaceutical Design. Unidades: EEFERP, FORP
Subjects: ANTIOXIDANTES, HIDROGÊNIO, INFLAMAÇÃO, FARMACOTERAPIA, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOGUEIRA, Jonatas Evandro e BRANCO, Luiz Guilherme de Siqueira. Recent advances in molecular hydrogen research reducing exercise-induced oxidative stress and inflammation. Current Pharmaceutical Design, v. 27, n. 5, p. 731-736, 2021Tradução . . Disponível em: https://doi.org/10.2174/1381612826666201113100245. Acesso em: 23 ago. 2024.
APA
Nogueira, J. E., & Branco, L. G. de S. (2021). Recent advances in molecular hydrogen research reducing exercise-induced oxidative stress and inflammation. Current Pharmaceutical Design, 27( 5), 731-736. doi:10.2174/1381612826666201113100245
NLM
Nogueira JE, Branco LG de S. Recent advances in molecular hydrogen research reducing exercise-induced oxidative stress and inflammation [Internet]. Current Pharmaceutical Design. 2021 ; 27( 5): 731-736.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/1381612826666201113100245
Vancouver
Nogueira JE, Branco LG de S. Recent advances in molecular hydrogen research reducing exercise-induced oxidative stress and inflammation [Internet]. Current Pharmaceutical Design. 2021 ; 27( 5): 731-736.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/1381612826666201113100245
Artigo de periodico
Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease (2015)
Maranhão, Raul Cavalcante ; Leite, Antonio Carlos de Arruda
Source: Current Pharmaceutical Design. Unidade: FCF
Subjects: INFLAMAÇÃO, ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante e LEITE, Antonio Carlos de Arruda. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, v. 21, n. 9, p. 1196-1204, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612820666141013150714. Acesso em: 23 ago. 2024.
APA
Maranhão, R. C., & Leite, A. C. de A. (2015). Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, 21( 9), 1196-1204. doi:10.2174/1381612820666141013150714
NLM
Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/1381612820666141013150714
Vancouver
Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2024 ago. 23 ] Available from: https://doi.org/10.2174/1381612820666141013150714
Trabalho de evento-resumo
Expression of IP-10 and MCP-1 and chemokines receptors CXCR3 and CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts (2008)
Crispim, C. O. J.; Martelli-Palomino, G.; Rassi, D. M.; Costa, R.; Silva, J.; Mendes Júnior, C. T.; Saber, L. T.; Donadi, Eduardo Antonio
Source: Abstracts Book. Conference titles: Annual Meeting of the International Immunology. Unidade: FMRP
Subjects: NEFROPATIAS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRISPIM, C. O. J. et al. Expression of IP-10 and MCP-1 and chemokines receptors CXCR3 and CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. 2008, Anais.. Al-Ain: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2008. . Acesso em: 23 ago. 2024.
APA
Crispim, C. O. J., Martelli-Palomino, G., Rassi, D. M., Costa, R., Silva, J., Mendes Júnior, C. T., et al. (2008). Expression of IP-10 and MCP-1 and chemokines receptors CXCR3 and CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. In Abstracts Book. Al-Ain: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Crispim COJ, Martelli-Palomino G, Rassi DM, Costa R, Silva J, Mendes Júnior CT, Saber LT, Donadi EA. Expression of IP-10 and MCP-1 and chemokines receptors CXCR3 and CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. Abstracts Book. 2008 ;[citado 2024 ago. 23 ]
Vancouver
Crispim COJ, Martelli-Palomino G, Rassi DM, Costa R, Silva J, Mendes Júnior CT, Saber LT, Donadi EA. Expression of IP-10 and MCP-1 and chemokines receptors CXCR3 and CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. Abstracts Book. 2008 ;[citado 2024 ago. 23 ]

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Indexado em